检索

标题
作者
Rare clinical variant of palmoplantar keratoderma
Novikov Y., Pravdina O., Zykova E., Gamza S.
Fibroz pecheni: vozmozhnosti obratnogo razvitiya
Vinnitskaya E., Yunusova Y.
Efficiency of a medical product based on hypertonic sodium chloride (7%) and sodium hyaluronate (0.1%) in experimental pulmonary fibrosis model
Semivelichenko E., Ivkin D., Okovity S., Karev V.
Multislice computer tomography perfusion imaging of the hepatosplenic zone in patients with diffuse liver diseases
Mezikova E., Zavadovskaya V., Beloborodova E., Dolgalev I., Tonkikh O.
Liver fibrosis in chronic hepatitis C: view of the problem in era of interferon-free treatment
Bakulin I., Vinnitskaya E., Polukhina A., Sandler Y.
Khronicheskiy virusnyy gepatit S v svete sovremennykh Rossiyskikh i Evropeyskikh rekomendatsiy
Polunina T.
HEPATIC FIBROSIS: MECHANISMS OF DEVELOPMENT AND TREATMENT ISSUES
Yakovenko E., Ivanov A., Pryanishnikova A., Yakovenko A., Agafonova N., Yakovenko E., Yakovenko A., Ivanov A., Agafonov N., AS Pryanishnikova -.
Rational approach to diagnostics and treatment of chronic viral hepatitis C
Maev I., Polunina T., Polunina E., Majev I., Polunina T., Polunina E.
Cystic fibrosis register in the Astrakhan region: state of the problem according to 2021 data
Sergienko D., Bashkina O.
CYSTIC FIBROSIS: EVENTS AND NEWS
Simonova O., Gorinova Y., Ignatova A., Shestopalove E., Mukhina M., Popova O.
13C methacetin breath test for the evaluation of liver functional reserves
Bakulin I., Medvedev Y.
OSTEOPOROZ V PRAKTIKE PUL'MONOLOGA
Baranova I.
DORNASE ALPHA (PULMOZYME) FOR THE COMPLEX TREATMENT OF BRONCHOPULMONARY PROCESS IN CYSTIC FIBROSIS PATIENTS.
Sherman V., Kapranov N., Kashirskaya N., Sherman V., Kapranov N., Kashirskaya N.
Clinical significance of dornase alfa (Pulmozyme) in complex therapy of early age children suffering cystic fybrosis
Shelepneva N., Kashirskaya N., Sherman V., Kapranov N., Shelepneva N., Kashirskaya N., Sherman V., Kapranov N.
About the mechanism of development of acquired tethered cord syndrome in patients with lumbar osteochondrosis
Bektoshev O., Bektoshev R., Babazhanov A., Akhmedov A., Nizamova Y., Bektoshev S.
Multiple myeloma, secondary liver amiloidosis. Description of the clinical case
Bakulin I., Oganezova I., Medvedeva O., Petrenko V., Medvedev Y.
Comparative analysis of the diagnosis of liver fibrosis by M- and XL-elastometry in patients with chronic hepatitis C
Galushko M., Bakulin I., Timokhina A.
DIFFERENTIAL DIAGNOSIS AND GENERAL PRINCIPLES OF THERAPY OF CHRONIC DIARRHEA IN CHILDREN
Bel'mer S., Gasilina T., Belmer S., Gasilina T.
Epidemiology and genetics of cystic fibrosis in Udmurt Republic
Simanova T., Ozhegov A., Simanova T., Ozhegov A.
Factors associated with non-response to etiological therapy in patients with Opisthorchis felineus invasion
Tsukanov V., Tonkikh Y., Vasyutin A.
FEATURES OF ASSOCIATED TRAITS OF 3272-16T>A MUTATION IN CYSTIC FIBROSIS IN CHILDREN: DESCRIPTION OF THREE CASES
Shadrina V., Krasovsky S., Furman E.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.
CURRENT APPROACHES TO THE THERAPY OF CYSTIC FIBROSIS
Kapranov N., Asherova I., Kapranov N., Asherova I.
EFFECT OF MUTATIONS IN THE CFTR GENE ON COURSE OF CYSTIC FIBROSIS IN CHILDREN
Sergienko D., Bashkina O., M Galimzianov -., Sergienko D., Bashkina O., Galimzyanov K.
Comorbid patient with rheumatoid arthritis: increasing the accuracy of diagnostics of non-alcoholic fatty liver disease with prediction of liver fibrosis
Korolchuk I., Kucheryavy V., Kovalenko R.
RATIONAL MUSCOLYTIC THERAPY IN THE THERAPEUTIC PRACTICE
Babak S., Gorbunova M., Malyavi A.
ANALIZ VLIYaNIYa FIBROZA PEChENI NA EFFEKTIVNOST' I BEZOPASNOST' ANTIKhELIKOBAKTERNOY TERAPII
Andreev D., Maev I., Dicheva D., Kucheryavyy Y., Partsvania-Vinogradova E.
IDIOPATHIC PULMONARY FIBROSIS: WHETHER WE ARE CLOSE TO CONVENTIONAL GUIDELINES FOR DIAGNOSIS AND TREATMENT?
Fomin V., Popova E., Lebedeva M., Shovskaya T., Fomin V., Popova Y., Lebedeva M., Shovskaya T.
CHANGE OF CONGENITAL IMMUNITY FACTORS IN CHILDREN WITH CYSTIC FIBROSIS
Sergienko D., Bashkina O., Galimzianov M., Sergienko D., Bashkina O., Galimzyanov K.
Features of the course of chronic lung diseases in children at the present stage
Vyazovaya I., Ikhsanov S., Averina I.
PROGNOSTIC SIGNIFICANSE OF THE POLYMORPHISM OF GENES ASSOCIATED WITH THE RISK OF TYPE 2 DIABETES MELLITUS AND OBESITY, FOR THE DEVELOPMENT OF LIVER FIBROSIS AND HEPATIC STEATHOSIS IN PATIENTS WITH NON-ALCOHOLIC FAT LIVER DISEASE
Sandler Y., Polukhina A., Vinnitskaya E., Bakulin I., Borunova Z., Keyyan V.
ROL' ALLEL'NYKh VARIANTOV GENOV SVERTYVANIYa KROVI V SKOROSTI PROGRESSIROVANIYa FIBROZA PRI KhRONIChESKIKh ZABOLEVANIYaKh PEChENI
Starostina E., Fastovets S., Samokhodskaya L., Rozina T., Ignatova T., Krasnova T., Mukhin N.
TERAPIYa EKZOKRINNOY NEDOSTATOChNOSTI PODZhELUDOChNOY ZhELEZY U DETEY, BOL'NYKh MUKOVISTsIDOZOM, NA PRIMERE PRIMENENIYa PREPARATA KREON
Kashirskaya N., Kapranov N.
RECURRENT POLYSINUSITIS AS LEADING CLINICAL SIGN OF CYSTIC FIBROSIS: SUCCESSFUL ENDONASAL USE OF DORNASE ALFA
Asherova I., Tarakanova V., Asherova I., Tarakanova V.
The frequency of liver fibrosis and clinical symptoms in patients with opisthorchiasis
Gorchilova E., Tsukanov V., Tonkikh Y., Vasyutin A., Rzhavicheva O.
CLINICAL RELEVANCE OF THE DETERMINATION OF SURFACTANT PROTEIN A AND D IN ASSESSMENT OF ACTIVITY OF PULMONARY SARCOIDIDOSIS
Beketov V., Lebedeva M., Mukhin N., Popova E., Serova A., Solomka V., Kondrashov A., Ponomarev A., Brovko M.
SOVREMENNYE VOZMOZhNOSTI DIAGNOSTIKI I LEChENIYa TsIRROZA PEChENI U DETEY
Surkov A.
PHARMACOLOGICAL EFFECTS AND CLINICAL FEATURES OF THE REFERENCE PREPARATION SILYMARIN
Gubergrits N., Fomenko P., Lukashevich G., Golubova O., Gubergritc N., Fomenko P., Lukashevich G., Golubova O.
Clinical significance of ETN-organs injury in children with cystic fibrosis and their treatment on current stage
Kapranov N., Martynova I., Mosina V., Kashirskaya N., Kapranov N., Martynova I., Mosina V., Kashirskaya N.
Targeted therapy in patients with cystic fibrosis in the Astrakhan region: first experience
Sergienko D., Bashkina O., Kuznetsova T.
Rationale for adequate enzyme replacement therapy for children with cystic fibrosis: a cross-sectional study
Maksimycheva T., Kondratyeva E., Sorvacheva T., Evdokimova T.
Mycogenic sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis patients: results of prospective study
Kozlova Y., Sobolev A., Borzova Y., Suslova I., Aak O., Ignatyeva S., Bogomolova T., Stepanenko T., Orlov A., Klimko N.
SOVREMENNYE FARMAKOTERAPEVTIChESKIE PODKhODY K LEChENIYu MUKOVISTsIDOZA
Kashirskaya N., Kapranov N.
MESTO PUNKTsIONNOY BIOPSII V DIAGNOSTIKE KhRONIChESKIKh DIFFUZNYKh ZABOLEVANIY PEChENI
Pavlov C., Glushenkov D., Ivashkin V.
Idiopathic interstitial pneumonia: peculiarities of clinical picture and treatment
Avdeev S., Avdeev S.
1 - 45 的 45 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##